lenvatinib,sorafenib,camrelizumab,rivoceranib
bayer,eisai,jiangsu hengrui pharmaceuticals,elevar therapeutics
['sorafenib', 'hcc', 'lenva']
one more combination in hcc doing better over sorafenib? but why not control arm as lenvatinib?? #esmo22 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists